Divi’s Laboratories saw no growth in patent filings and highest growth of 0.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Divi’s Laboratories’s patent filings and grants. Buy the databook here.

Divi's Laboratories has been focused on protecting inventions in Spain(ES) with one publication in Q2 2024

The Spain(ES) Patent Office dominates the patent grants with nearly 100% of grants. The Spain(ES) patent Office are among the top ten patent offices where Divi's Laboratories is filings its patents. Among the top granted patent authorities, Divi's Laboratories has 100% of its grants in Spain(ES).

Bial Holding and FMC could be the strongest competitors for Divi's Laboratories

In terms of grant share, Divi's Laboratories stands in eighth position among its competitors. Bial Holding and FMC secured the top positions according to recent patent publication data.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Seizures related patents lead Divi's Laboratories portfolio

Divi's Laboratories has highest number of patents in seizures.

For comprehensive analysis of Divi's Laboratories's filings and grants, buy the databook here.